beta-cryptoxanthinFinding
Beta-cryptoxanthin decreases alanine aminotransferase
lowersModerate evidenceFinding
01 · The sentence it was drawn from
“In addition, patients in the β-cryptoxanthin group only showed a greater 12-week reduction in serum level of ALT, compared to those in the control group (for ALT: mean difference − 9.6 IU/L; p = 0.005).”
beta-cryptoxanthin
Alanine aminotransferase
lowers
Effect as reported
−9.6mean difference
- Who
- Iranian overweight/obese adults with moderate-to-severe non-alcoholic fatty liver disease; the same 500 kcal/day-deficit normal-protein diet in both arms; intention-to-treat, multivariable-adjusted ANCOVA contrast against the control arm
- Dose studied
- 6 mg/day β-cryptoxanthin, one 600 mg capsule (powder 1% β-cryptoxanthin, 99% starch) daily after dinner, 12 weeks
Moderate evidencePMID 33081717 · 2020
02 · The study
- Study
- RCT
- Duration
- 3 months
Evidence, by strength
- strong
- moderatethis finding
- limited
- very limited
- insufficient
03 · The paper
BMC gastroenterology04 · To cite this finding
This address does not changehttps://catalystproject.ai/e/01M7GECAW2D22RW3DVAC91XGKC